Many people also report vomiting, diarrhea, constipation, bloating, belching, gas, heartburn, and abdominal pain
It could lead to dangerous adverse reactions as described on the FDA warning label, which include: Acute kidney injury Cardiovascular effects Diabetic retinopathy Gallbladder events Gastrointestinal issues Hypoglycemia Pancreatic cancer and pancreatitis An additional potential risk of using Ozempic is developing thyroid C-cell tumors
a 2026 UK survey found 47% of GLP-1 users modify their dosing to save money
Properly managing your treatment is simple once you know the rules
blood sugar) into your bodys cells, where its used for energy
Further into 2027 and beyond, both Novo Nordisk and Lilly will be launching a suite of newer generation medicines, including Lillys highly anticipated retatrutide